ASSGP

What ASSGP does

ASSGP (Schweizerischer Fachverband für Selbstmedikation / Association Suisse des Spécialités Pharmaceutiques Grand Public) is a Swiss trade association founded in 1969 and headquartered at Effingerstrasse 14 in Bern. The association represents manufacturers and distributors of non-prescription (OTC) medicines, dietary supplements, and substance-based medical devices in Switzerland. Its members account for approximately 74% of Swiss OTC drug revenue and 55% of revenue across all covered categories, with a total roster of 43 ordinary members, 7 associated members, and 36 supporting members.

ASSGP does not sell commercial products or operate technology platforms; its core activities are policy advocacy, industry representation, networking, and dissemination of regulatory and market information to members. Members must comply with the Pharmakodex Schweiz (Swiss Pharma Code) and ASSGP statutes, providing a self-regulatory backbone to the Swiss self-medication sector. The association is a member of AESGP in Brussels and, through that federation, of the WHO-recognized Global Self-Care Federation, extending its influence into European and global self-care policy forums.

Revenue is derived from membership fees, which are set annually by the General Assembly. Ordinary and associated members pay fees based on Swiss market share, while supporting members (e.g., consultancies, law firms, distribution partners) pay a fixed annual fee. The association is governed by a General Assembly, a Vorstand (Board of Directors) led by a Präsident and Vizepräsident, and a Geschäftsführer (Managing Director) responsible for day-to-day operations. Board members include senior representatives from Bayer, Haleon, Schwabe Pharma, Similasan, Wala, and Verfora, among others, reflecting the dominant OTC industry players in Switzerland.

Name

ASSGP

Legal name

Schweizerischer Fachverband für Selbstmedikation (ASSGP)

Website

https://assgp.ch

Company type

Private

Founded year

1969

Operating status

Operating

Short description

ASSGP is a Swiss trade association founded in 1969 representing manufacturers and distributors of OTC medicines, dietary supplements, and medical devices in Switzerland. Its members account for roughly 74% of Swiss OTC drug revenue, and the association provides advocacy, self-regulation, and member services.

Ownership category

akta.pro rank

Headquarters

HQ city

Bern

HQ country

Switzerland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Marketing channels1 record

Core offering

ASSGP is a Swiss trade association that advocates for comprehensive, safe, and high-quality self-medication in society, politics, and legislation. It represents manufacturers and distributors of non-prescription (OTC) medicines, dietary supplements, and substance-based medical devices in Switzerland, and provides members with representation in health and pharmaceutical policy, industry information, networking opportunities, and participation in working groups and exchange with authorities and stakeholders.

Product overview

ASSGP is a trade association (Schweizerischer Fachverband für Selbstmedikation / Association Suisse des Spécialités Pharmaceutiques Grand Public) established in 1969 that advocates for self-medication in Swiss healthcare. The association represents manufacturers and distributors of non-prescription (OTC) medicines, dietary supplements, and substance-based medical devices. ASSGP's members account for approximately 74% of OTC medicine sales and 55% of all non-prescription product sales in Switzerland. The association does not offer commercial products or services but provides advocacy, industry representation, networking, and information services to its member companies.

Differentiator

Problem solved

Functional benefit

Products and services

• Ordentliche Mitgliedschaft (Ordinary Membership) Membership category for Swiss manufacturers and distributors of non-prescription (OTC) medicines, dietary supplements, and substance-based medical devices. Members pay fees based on market share and receive advocacy, policy representation, networking, and participation in working groups. Currently 43 ordinary members, representing more than 74% of Swiss OTC drug revenue.
• Assoziierte Mitgliedschaft (Associated Membership) Membership category for companies associated with ordinary members within the same corporate group. Associated members pay market-share-based fees and participate in the association's advocacy and information services. Currently 7 associated members.
• Fördermitgliedschaft (Supporting Membership) Supporting membership category for companies, organizations, and individuals active in the environment of ASSGP members and interested in the association's work (e.g., law firms, pharmacy groups, consultancies). Supporting members pay a fixed annual fee and gain access to industry information, networking opportunities, and advisory services. Currently 36 supporting members.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Two partnerships are on record, tiered core.

• AESGP (Association Européenne des Spécialités Pharmaceutiques Grand Public)coreOthersASSGP is a member of AESGP in Brussels, the European association of non-prescription medicine manufacturers. This membership enables ASSGP to advocate for Swiss self-medication interests at the European level.
• GSCF (Global Self-Care Federation)coreOthersAESGP is a member of the Global Self-Care Federation, which is recognized by the World Health Organization (WHO) as a non-governmental organization.

Scale indicators4 records

Recent moves4 records

Expansion highlights3 records

Direct peers

• AFIPA (Association Française de l'Industrie Pharmaceutique pour une Automédication Responsable): French trade association for responsible self-medication industry. Direct functional equivalent of ASSGP at the national level in France — same OTC advocacy remit, similar member types.
• BAH (Bundesverband der Arzneimittel-Hersteller): German trade association of pharmaceutical manufacturers covering OTC, prescription, and consumer health products. Comparable member base and self-medication advocacy mandate, with broader scope than ASSGP.
• Global Self-Care Federation (GSCF): WHO-recognised global federation for self-care manufacturers. ASSGP reaches GSCF via AESGP. Closest peer in terms of advocacy remit, member profile (OTC manufacturers), and policy focus.
• Consumer Healthcare Products Association (CHPA): US trade association for OTC drug, dietary supplement, and consumer medical device manufacturers. Comparable remit, member profile (Bayer, Haleon-style multinationals), and self-regulatory function — directly analogous to ASSGP at national level.
• AESGP (Association Européenne des Spécialités Pharmaceutiques Grand Public): Brussels-based European federation of OTC/self-medication industry associations. ASSGP is a direct national member of AESGP, making it the most structurally comparable peer — same mission (OTC advocacy), same member base type, broader geography.

Regional players

• National Pharmacy Association (NPA): UK community pharmacy trade body. Functionally comparable as a national association engaging on OTC/self-medication policy, though UK-focused rather than Swiss. Useful benchmark for ASSGP's advocacy scope.
• pharmaSuisse: Swiss pharmacists' professional association. Adjacent rather than competing — represents the dispensing side of self-medication in Switzerland, sharing the same Swiss policy agenda ASSGP influences.
• Scienceindustries: Swiss trade association for the chemistry, pharma, and life sciences industries. Overlapping Swiss membership and policy remit on broader pharma regulation; ASSGP's members likely overlap with Scienceindustries' constituents.
• Interpharma: Swiss association of research-based pharmaceutical companies. Comparable Swiss trade-association structure and member types, though focused on Rx pharma rather than OTC/self-medication — partial overlap on broader pharma policy.

Broad incumbents

• EFPIA (European Federation of Pharmaceutical Industries and Associations): European federation of the research-based pharmaceutical industry. Broader incumbent peer covering Rx and OTC; ASSGP's multinational members (Bayer, Haleon, Schwabe) are also represented through EFPIA — useful as a strategic incumbent benchmark.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ASSGP